Literature DB >> 32337590

Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

Jiuxin Qu1, Chi Wu1, Xiaoyong Li1, Guobin Zhang1, Zhaofang Jiang1, Xiaohe Li2, Qing Zhu1, Lei Liu3.   

Abstract

We profiled the serological responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid (N) protein and spike (S) glycoprotein. The majority of the patients developed robust antibody responses between 17 and 23 days after illness onset. Delayed, but stronger, antibody responses were observed in critical patients.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; IgG; IgM; SARS-CoV-2; serologic responses

Year:  2020        PMID： 32337590      PMCID： PMC7197626          DOI： 10.1093/cid/ciaa489

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  114 in total

Review 1.  Severe Acute Respiratory Syndrome Coronavirus 2: Manifestations of Disease and Approaches to Treatment and Prevention in Humans.

Authors:  Michael E Watson; Kengo Inagaki; Jason B Weinberg
Journal:  Comp Med       Date:  2021-09-17       Impact factor: 0.982

Review 2.  COVID-19 Diagnostic Strategies Part II: Protein-Based Technologies.

Authors:  Tina Shaffaf; Ebrahim Ghafar-Zadeh
Journal:  Bioengineering (Basel)       Date:  2021-04-28

3.  Dynamics of SARS-CoV-2 with waning immunity in the UK population.

Authors:  Thomas Crellen; Li Pi; Emma L Davis; Timothy M Pollington; Tim C D Lucas; Diepreye Ayabina; Anna Borlase; Jaspreet Toor; Kiesha Prem; Graham F Medley; Petra Klepac; T Déirdre Hollingsworth
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2021-05-31       Impact factor: 6.237

4.  SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors.

Authors:  Evangelos Terpos; Dimitris Stellas; Margherita Rosati; Theodoros N Sergentanis; Xintao Hu; Marianna Politou; Vassiliki Pappa; Ioannis Ntanasis-Stathopoulos; Sevasti Karaliota; Jenifer Bear; Duncan Donohue; Maria Pagoni; Elisavet Grouzi; Eleni Korompoki; George N Pavlakis; Barbara K Felber; Meletios A Dimopoulos
Journal:  Eur J Intern Med       Date:  2021-05-18       Impact factor: 7.749

5.  Clinical and etiological analysis of co-infections and secondary infections in COVID-19 patients: An observational study.

Authors:  Shuyan Chen; Qing Zhu; Yanyu Xiao; Chi Wu; Zhaofang Jiang; Lei Liu; Jiuxin Qu
Journal:  Clin Respir J       Date:  2021-04-19       Impact factor: 1.761

6.  The association between obesity and peak antibody titer response in COVID-19 infection.

Authors:  Shelly Soffer; Benjamin S Glicksberg; Eyal Zimlichman; Orly Efros; Matthew A Levin; Robert Freeman; David L Reich; Eyal Klang
Journal:  Obesity (Silver Spring)       Date:  2021-08-02       Impact factor: 9.298

7.  Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.

Authors:  Sally Esmail; Michael J Knauer; Husam Abdoh; Courtney Voss; Benjamin Chin-Yee; Peter Stogios; Almagul Seitova; Ashley Hutchinson; Farhad Yusifov; Tatiana Skarina; Elena Evdokimova; Suzanne Ackloo; Lori Lowes; Benjamin D Hedley; Vipin Bhayana; Ian Chin-Yee; Shawn S-C Li
Journal:  Cell Rep Methods       Date:  2021-05-12

8.  Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort.

Authors:  Amit Saxena; Allison Guttmann; Mala Masson; Mimi Y Kim; Rebecca H Haberman; Rochelle Castillo; Jose U Scher; Kristina K Deonaraine; Alexis J Engel; H Michael Belmont; Ashira D Blazer; Jill P Buyon; Ruth Fernandez-Ruiz; Peter M Izmirly
Journal:  Lancet Rheumatol       Date:  2021-05-27

9.  Highly Sensitive and Specific Multiplex Antibody Assays To Quantify Immunoglobulins M, A, and G against SARS-CoV-2 Antigens.

Authors:  Carlota Dobaño; Marta Vidal; Rebeca Santano; Alfons Jiménez; Jordi Chi; Diana Barrios; Gemma Ruiz-Olalla; Natalia Rodrigo Melero; Carlo Carolis; Daniel Parras; Pau Serra; Paula Martínez de Aguirre; Francisco Carmona-Torre; Gabriel Reina; Pere Santamaria; Alfredo Mayor; Alberto L García-Basteiro; Luis Izquierdo; Ruth Aguilar; Gemma Moncunill
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

Review 10.  The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation.

Authors:  Zhihua Bai; Ying Cao; Wenjun Liu; Jing Li
Journal:  Viruses       Date:  2021-06-10       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.